14 results
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... 40, F:M 9:1 • Clinical ... Photosensitivity, Alopecia ... Usual therapeutic management ... Erythematosus #Diagnosis #Management
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... Photosensitivity, Alopecia ... Usual therapeutic management ... rheumatology #diagnosis #management
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Family engagement Critical ... will vary with clinical ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
HIV-AIDS Preventing Clinical ... and preventing clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
develops on the background ... fever syndromes Clinical ... Fever is the main clinical ... erythematosus [SLE ... Syndrome #Diagnosis #Management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
prolongation, alopecia ... skin carcinoma, alopecia ... tolerable • Limited clinical ... #valleyfever #management ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
prolongation, alopecia ... skin carcinoma, alopecia ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... salivary ducts Clinical ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
as substantial clinical ... least 1 year (AI)—see ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
• Use until clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology